Burning Rock Biotech Ltd.-ADRBNR
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 16 institutions reported holding Burning Rock Biotech Ltd.-ADR (BNR) in their 13F filings, unchanged from Q4 2025. 3 opened new positions and 2 sold out. The largest holders were Kynam Capital Management, LP ($19.8M), CRCM LP ($4.6M) and Renaissance Technologies ($571K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Burning Rock Biotech Ltd.-ADR
- CUSIP
- 12233L206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $288K |
| Exits | 2 | $848K |
All 13F filers, Q4 2025 → Q1 2026: 258,278 shares bought and 257,282 shares sold, net +996 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Kynam Capital Management, LP | 1.26% | Add +23.4% | 1,227,555 | $19.8M |
| CRCM LP | 3.26% | Reduce -42.6% | 282,097 | $4.6M |
| Renaissance Technologies | 0.00% | Add +13.8% | 35,407 | $571K |
| Amova Asset Management Americas, Inc. | 0.01% | Reduce -5.3% | 30,137 | $488K |
| Sumitomo Mitsui Trust Group, Inc. | 0.00% | Reduce -5.3% | 30,137 | $486K |
| Bank of America Corp. | 0.00% | Reduce -0.1% | 29,164 | $470K |
| Redwood Wealth Management Group, LLC | 0.13% | Reduce -8.7% | 18,278 | $295K |
| Citadel Advisors | 0.00% | New | 17,669 | $285K |
| Morgan Stanley | 0.00% | Add +29.0% | 15,272 | $246K |
| HSG Holding Ltd | 0.00% | No change | 21,212 | $62K |
| BNP Paribas Financial Markets | 0.00% | No change | 2,800 | $45K |
| UBS Group AG | 0.00% | Reduce -65.1% | 408 | $7K |
| JPMorgan Chase & Co. | 0.00% | New | 187 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 28 | $452 |
| BlackRock, Inc. | 0.00% | Reduce -60.0% | 4 | $65 |
| Citigroup Inc. | 0.00% | No change | 1 | $16 |
"% of holder's portfolio" is BNR's weight in each manager's 13F, not the share of Burning Rock Biotech Ltd.-ADR the manager owns.